Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role

January 11, 2023

TORONTO, Jan. 11, 2023 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB:MVMDF) (FRA: 20MP), an early-stage biotech business centered around the implementation, licensing and reselling of key technologies and formulations, today announced that Dr. Azhar Rana, the Company’s Chief Medical Officer (“CMO”), will be transitioning to an advisory capacity effective February 1, 2023.

Read more at globenewswire.com

Related news for (MVMDF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.